Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation
{{output}}
Neuroinflammation characterizes multiple neurologic diseases, including primary inflammatory conditions such as multiple sclerosis and classical neurodegenerative diseases. Aberrant activation of the innate immune system contributes to disease progression, but... ...
